Luke Tzu-Chi Liu

Medicine · Health Sciences

9h-index458citations24works2.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

SARS-CoV-2 and COVID-19 Research(19), COVID-19 Clinical Research Studies(12), Viral gastroenteritis research and epidemiology(9), Vaccine Coverage and Hesitancy(7), Viral Infections and Immunology Research(7)

Publications24 total

Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study
Vaccines·2024· 2 citedOpen Access
Long-Term Immunogenicity Study of an Aluminum Phosphate-Adjuvanted Inactivated Enterovirus A71 Vaccine in Children: An Extension to a Phase 2 Study
2023Open Access
Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901-Beta SARS-CoV-2 Vaccine in Adults: A Phase I, Prospective, Randomized, Open-Labeled Study
Vaccines·2023· 2 citedOpen Access
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine
Zenodo (CERN European Organization for Nuclear Research)·2023Open Access
A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for the Medigen COVID-19 protein vaccine
Vaccine·2023· 3 citedOpen Access
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: a randomized phase 2 trial
npj Vaccines·2022· 14 citedOpen Access
Neutralization of SARS-CoV-2 Omicron BA.4/BA.5 subvariant by a booster dose of bivalent adjuvanted subunit vaccine containing Omicron BA.4/BA.5 and BA.1 subvariants
2022Open Access
A Phase I, Prospective, Randomized, Open-labeled Study to Evaluate the Safety, Tolerability, and Immunogenicity of Booster Dose with MVC-COV1901 or MVC-COV1901(Beta) SARS-CoV-2 Vaccine in Adults
2022· 5 citedOpen Access
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in Taiwanese adolescents: A double-blind, randomized, placebo-controlled phase 2 trial
Research Square (Research Square)·2022Open Access
Protection of hamsters challenged with SARS-CoV-2 after two doses of MVC-COV1901 vaccine followed by a single intranasal booster with nanoemulsion adjuvanted S-2P vaccine
Scientific Reports·2022· 9 citedOpen Access
Hamsters Protected from SARS-CoV-2 Delta Variant Challenge after Two Doses of Adjuvanted SARS-CoV-2 Recombinant Spike Protein (S-2P) and One Dose of Beta S-2P
The Journal of Infectious Diseases·2022· 6 citedOpen Access
Safety and immunogenicity of SARS-CoV-2 vaccine MVC-COV1901 in adolescents in Taiwan: A double-blind, randomized, placebo-controlled phase 2 trial
2022· 6 citedOpen Access
Protection of Hamsters Challenged with SARS-CoV-2 after Two Doses of MVC-COV1901 Vaccine Followed by a Single Intranasal Booster with Nanoemulsion Adjuvanted S-2P Vaccine
2022Open Access
Prevalence and diversity of rotavirus A in pigs: Evidence for a possible reservoir in human infection
Infection Genetics and Evolution·2021· 31 citedOpen Access
Evaluating the Neutralizing Ability of a CpG-Adjuvanted S-2P Subunit Vaccine Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Variants of Concern
Clinical Infectious Diseases·2021· 17 citedOpen Access
Protection of Hamsters Challenged with SARS-CoV-2 Variants of Concern by Two Doses of MVC-COV1901 Vaccine Followed by a Single Dose of Beta Variant Version of MVC-COV1901
2021· 2 citedOpen Access
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
Scientific Reports·2021· 45 citedOpen Access
Evaluating the neutralizing ability of a CpG-adjuvanted S-2P subunit vaccine against SARS-CoV-2 Variants of Concern
2021· 5 citedOpen Access
CpG-adjuvanted stable prefusion SARS-CoV-2 spike protein protected hamsters from SARS-CoV-2 challenge
2021· 9 citedOpen Access
Sapoviruses detected from acute gastroenteritis outbreaks and hospitalized children in Taiwan
Journal of the Formosan Medical Association·2020· 14 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Charles Chen(17), Chia-En Lien(16), Meei‐Yun Lin(12), Tsun‐Yung Kuo(9), Yi‐Jiun Lin(9), John D. Campbell(6), Paula Traquina(6), Li‐Min Huang(6), Chung-Chin Wu(6), Wei-Hsuan Tang(6), Jinyi Cheng(5), Wei‐Cheng Lian(5), Cheng‐Hsun Chiu(5), Chien‐Yu Lin(5), Hao‐Yuan Cheng(5), Ya-Shan Chuang(5), Ting‐Yu Kuo(3), Fang‐Tzy Wu(3), Nan‐Chang Chiu(3), Boon‐Fatt Tan(3)